Oppenheimer Initiates Coverage On LeMaitre Vascular with Outperform Rating, Announces Price Target of $70
Portfolio Pulse from Benzinga Newsdesk
Oppenheimer analyst Suraj Kalia has initiated coverage on LeMaitre Vascular (NASDAQ:LMAT) with an Outperform rating and a price target of $70.
September 06, 2023 | 8:44 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
LeMaitre Vascular has been given an Outperform rating by Oppenheimer, with a price target of $70.
The Outperform rating from Oppenheimer indicates a positive outlook for LeMaitre Vascular. The price target of $70 suggests a potential upside for the stock. This could lead to increased investor interest and a potential rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100